Retrospective evaluation of fidaxomicin versus oral vancomycin for treatment of Clostridium difficile infections in allogeneic stem cell transplant

Author:

Prohaska Laura,Mahmoudjafari Zahra,Shune Leyla,Singh Anurag,Lin Tara,Abhyankar Sunil,Ganguly Siddhartha,Grauer Dennis,McGuirk Joseph,Clough Lisa

Publisher

Elsevier BV

Subject

Oncology,Hematology,General Medicine

Reference26 articles.

1. Incidence and outcomes of Clostridium difficile associated disease in hematopoietic stem cell transplant recipients;Guddatti;Int J Hematol,2014

2. Centers for Disease Control. Frequently asked questions about Clostridium difficile for healthcare providers. Centers for Disease Control webpage. [Updated 6 Mar 2012]. Available from: http://www.cdc.gov/HAI/organisms/cdiff/Cdiff_faqs_HCP.html. [Accessed 29 Aug 2016].

3. Clinical efficacy of fidaxomicin compared with vancomycin and metronidazole in Clostridium difficile infections: a meta-analysis and indirect treatment comparison;Cornely;J Antimicrob Chemother,2014

4. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA);Cohen;Infect Control Hosp Epidemiol,2010

5. Clostridium difficile: deleterious impact on hematopoietic stem cell transplantation;Callejas-Diaz;Curr Hematol Malig Rep,2014

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3